Literature DB >> 25371603

Saudi oncology society and Saudi urology association combined clinical management guidelines for testicular germ cell tumors.

Mohammed Alotaibi1, Shouki Bazarbashi2, Sultan Alkhateeb3, Ashraf Abusamra4, Danny Rabah5, Mubarak Almansour6, Esam Murshid7, Abdullah Alsharm8, Imran Ahmad9, Khalid Alghamdi10, Ahmad Saadeddin11, Abdullah Alghamdi12.   

Abstract

In this report, updated guidelines for the evaluation, medical, and surgical management of germ cell tumor of testes are resented. They are categorized according the stage of the disease using the tumor-node-metastasis staging system 7(th) edition. The recommendations are presented with supporting level of evidence.

Entities:  

Keywords:  Guidelines; Saudi; management; testicular germ cell tumors

Year:  2014        PMID： 25371603      PMCID： PMC4216532          DOI： 10.4103/0974-7796.140978

Source DB:  PubMed          Journal:  Urol Ann        ISSN： 0974-7796


  25 in total

1.  Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.

Authors:  K Fizazi; S Tjulandin; R Salvioni; J R Germà-Lluch; J Bouzy; D Ragan; C Bokemeyer; A Gerl; A Fléchon; J S de Bono; S Stenning; A Horwich; J Pont; P Albers; U De Giorgi; M Bower; A Bulanov; G Pizzocaro; J Aparicio; C R Nichols; C Théodore; J T Hartmann; H J Schmoll; S B Kaye; S Culine; J P Droz; C Mahé
Journal:  J Clin Oncol       Date:  2001-05-15       Impact factor: 44.544

2.  Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma--predominant testis cancer.

Authors:  C J Sweeney; B P Hermans; D K Heilman; R S Foster; J P Donohue; L H Einhorn
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

Review 3.  Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: a prospective multicenter study.

Authors:  H Schmidberger; M Bamberg; C Meisner; J Classen; C Winkler; M Hartmann; R Templin; T Wiegel; W Dornoff; D Ross; H J Thiel; C Martini; W Haase
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-09-01       Impact factor: 7.038

4.  Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group.

Authors:  G C Toner; M R Stockler; M J Boyer; M Jones; D B Thomson; V J Harvey; I N Olver; H Dhillon; A McMullen; V J Gebski; J A Levi; R J Simes
Journal:  Lancet       Date:  2001-03-10       Impact factor: 79.321

5.  International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.

Authors: 
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

6.  Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma.

Authors:  W J Reiter; T Brodowicz; S Alavi; C C Zielinski; W Kozak; U Maier; G Nöst; H Lipsky; M Marberger; C Kratzik
Journal:  J Clin Oncol       Date:  2001-01-01       Impact factor: 44.544

7.  Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.

Authors:  A Heidenreich; I A Sesterhenn; F K Mostofi; J W Moul
Journal:  Cancer       Date:  1998-09-01       Impact factor: 6.860

8.  Clinical stage I testis cancer: long-term outcome of patients on surveillance.

Authors:  P C Sogani; M Perrotti; H W Herr; W R Fair; H T Thaler; G Bosl
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

9.  Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide.

Authors:  P J Loehrer; R Lauer; B J Roth; S D Williams; L A Kalasinski; L H Einhorn
Journal:  Ann Intern Med       Date:  1988-10-01       Impact factor: 25.391

10.  Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.

Authors:  Peter Albers; Roswitha Siener; Susanne Krege; Hans-Uwe Schmelz; Klaus-Peter Dieckmann; Axel Heidenreich; Peter Kwasny; Maik Pechoel; Jan Lehmann; Sabine Kliesch; Kai-Uwe Köhrmann; Rolf Fimmers; Lothar Weissbach; Volker Loy; Christian Wittekind; Michael Hartmann
Journal:  J Clin Oncol       Date:  2008-05-05       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.